Trials / Completed
CompletedNCT03504306
Validation of Ventriject Determined Maximal Oxygen Uptake
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (actual)
- Sponsor
- University of Copenhagen · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This study aims to validate the use of the Ventriject product to estimate VO2 max, through a non-physically active test using ECG, echoseismography and echosonography.
Detailed description
this study will be composed of the following tests: * blood sample for measurement of blood values * blood pressure measurement to rule out risks affiliated with maximal effort testing * DXA body composition scanning * Measurement on ECG, echosonography and echoseismography with accelerometer, microphone and ECG wires * Measurements with phone (iPhone) * VO2 max assessment by maximal oxygen uptake testing on a training bike, using online oxygenmeasurement equipment * Hand-grip strength assessment
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Ventriject validation | comparing measurements from echocardiography, echoseismography to measurements of maximal oxygen uptake |
Timeline
- Start date
- 2018-04-23
- Primary completion
- 2018-12-31
- Completion
- 2018-12-31
- First posted
- 2018-04-20
- Last updated
- 2019-01-15
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03504306. Inclusion in this directory is not an endorsement.